Publication | Open Access
The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England
13
Citations
38
References
2022
Year
The base-case incremental cost-effectiveness ratio was estimated to be within the acceptable thresholds for cost effectiveness considered for England.
| Year | Citations | |
|---|---|---|
Page 1
Page 1